NO-mediated, endothelium-dependent relaxations of isolated arteries are blunted by ageing and high-fat diets, as well as by apolipoprotein E deletion. The present study was designed to test the hypothesis that apolipoprotein E deletion impairs endothelium-dependent responses to prostacyclin (IP) receptor activation.
Introduction
Prostacyclin, an unstable (half-life of 2 to 3 s) prostanoid generated by prostacyclin synthase from endoperoxides produced by COX (Vane, 1983; Smyth et al., 2009; Kawabe et al., 2010) , protects the vasculature by activating prostacyclin (IP) receptors of platelets, inhibiting their aggregation and adhesion, and of vascular smooth muscle cells, causing their relaxation (Fetalvero et al., 2007) . Because prostacyclin is readily degraded, a number of stable analogues have been developed for clinical use (Coleman et al., 1994) and one of these analogues, iloprost (used in the present study) is a potent agonist of IP receptors (Wise and Jones, 1996) . IP receptors are seven transmembrane G q -protein coupled receptors connected to stimulation of AC producing cAMP which in turn activates cAMP-activated PKA inhibiting platelet aggregation and inducing relaxation of vascular smooth muscle (Wise and Jones, 1996; Miggin and Kinsella, 2002) . In mice, prostacyclin prevents the initiation and progression of atherogenesis by reducing platelet activation and the interaction between leukocytes and the endothelium (Kobayashi et al., 2004) . When IP receptors are absent or dysfunctional, platelet aggregation and vascular smooth muscle cell proliferation are facilitated, promoting thrombosis and atherosclerosis respectively (Cheng et al., 2002; Fujino et al., 2004; Arehart et al., 2008; Yuhki et al., 2011) .
In isolated arteries, relaxations to prostacyclin are minimal when the endothelium is absent or if the production of NO by endothelial NOS (eNOS) is inhibited (Shimokawa et al., 1988) . The stimulation of eNOS by prostacyclin is likely to involves activation of AC in the endothelial cells while the endothelium-dependent relaxation of the underlying vascular smooth muscle is due to production of cGMP by soluble GC (sGC). cGMP, in turn, activates PKG to cause inhibition of the contractile process (Gao, 2016; Vanhoutte et al., 2016) . The NO-dependent response to prostacyclin is inhibited by IP receptor antagonists (Xavier et al., 2009) .
The plasma glycoprotein apolipoprotein E is synthesized mostly in the liver, the small intestine and the brain (Riddell et al., 1997) , as well as by macrophages (Linton and Fazio, 1999) . As apolipoprotein E promotes the uptake of circulating cholesterol, when it is dysfunctional or absent, hyperlipidaemia and atherosclerosis ensue (Mahley et al., 1990) . For example, apolipoprotein E-deficient (ApoE À/À ) mice exhibit marked hypercholesterolaemia and spontaneously develop atherosclerotic lesions, with an accelerated rate in young animals fed a Western-type diet (Zhang et al., 1992; Coleman et al., 2006; Lee et al., 2011) . After injury of the arterial wall, vascular smooth muscle contains apolipoprotein E, which exerts an anti-atherogenic role by binding to ApoER2 (Hui, 2004; Moore et al., 2004) . Endothelium-dependent, NO-mediated relaxations are blunted by ageing and high-fat diet . In ApoE À/À mice, these responses, in particular those mediated by G i -proteins (Vanhoutte, 2016) , decrease with age (Lee et al., 2011) . To the best of our knowledge, it is not known if the endothelium-dependent responses to IP receptor activation are modulated by the absence or presence of apolipoprotein E. Hence, our experiments here were designed to test the hypothesis that apolipoprotein E-knockout should inhibit endothelium-dependent responses to IP receptor activation and that such inhibition would be exacerbated by a high-fat diet, known to precipitate the pro-atherogenic effects of the deletion (Zhang et al., 1992; Coleman et al., 2006; Lee et al., 2011; Meyrelles et al., 2011) . However, the experimental findings revealed quite the contrary.
Methods

Animals
All the animal care and experimental procedures were approved by the Committee on the Use of Live Animals in Teaching and Research of the University of Hong Kong. Animal studies are reported in compliance with the ARRIVE guidelines (Kilkenny et al., 2010; McGrath and Lilley, 2015) . Male ApoE +/+ (C57 BL/6) and ApoE À/À (on a C57 BL/6 background) mice were used for the study. The ApoE +/+ mice were purchased from the Laboratory Animal Unit of the University of Hong Kong. The ApoE À/À mice were purchased from Jackson Laboratory (Bar Harbor, ME, USA) and bred in the Laboratory Animal Unit. All mice were kept in a temperature-controlled room (21 ± 1°C) with a 12-h light/dark cycle. They had free access to water and normal chow (Lab Diet 5053; Purina Mills Inc., Richmond, IN, USA). Some ApoE +/+ and ApoE À/À littermates were fed a high-fat and high-cholesterol diet [HFD; D12309 (Research Diet, New Brunswick, NJ, USA)] for 29 to 32 weeks, starting at the age of 5 weeks), while others were fed normal chow (NC) in parallel as time controls. On the experimental day, the mice were anaesthetised with an intraperitoneal injection of pentobarbital sodium (70 mg·kg À1 ; Ganes Chemicals, Pennsville, NJ, USA). The aortae were isolated and dissected for ex vivo studies.
Isometric tension measurements
The aortae were placed in ice-cold modified Krebs-Ringer solution of the following composition (mM): NaCl 120, KCl 4.76, CaCl 2 2.5, MgSO 4 1.18, NaHCO 3 25.0, NaH 2 PO 4 1.18, glucose 5.5 and EDTA 0.026, pH 7.4 (control solution). After carefully removing the adhering fat and connective tissue, aortae with or without (see below) endothelium were cut into rings (approximately 2 mm in length); they were suspended between stainless steel wires (45 μm in diameter) in Halpern-Mulvany myographs (Danish Myo Technology A/S, Denmark), filled with warm (maintained at 37°C) aerated (95% O 2 /5% CO 2 ) control solution; an analytical system (PowerLab 4SP, AD Instruments, Colorado Springs, CO, USA) was used to record isometric tension. The rings were allowed to equilibrate for 30 min at basal tension (5 mN). They were then stretched step by step and exposed to KCl solution (60 mM) to determine the optimal distension of each ring; the contraction to KCl at the optimal distension was used as the reference contraction. Rings responding to KCl with contractions less than 2 mN were discarded. To demonstrate endothelial presence, rings were exposed to phenylephrine (10 À6 M) followed by ACh (10 À6 M); relaxations to ACh reaching more than 70% of the phenylephrine-induced contraction were accepted as indicating sufficient presence of endothelial cells, permitting inclusion of the experimental data obtained.
To examine responses of vascular smooth muscle per se, a Triton solution (0.3 mL; 0.5% in control solution) was perfused through the lumen of the arterial ring to remove the endothelial cells; the successful removal of the endothelium was confirmed by the absence of relaxation upon administration of ACh.
To remove extracellular calcium, the rings were washed five to six times in calcium-free Krebs-Ringer solution after obtaining the reference contraction to KCl.
To examine the effects of exogenous apolipoprotein E protein on iloprost-induced relaxations, rings were incubated with or without recombinant mouse apolipoprotein E protein (20 μg·mL À1 ) for 1 h before suspension in the Halpern-Mulvany myographs.
Endothelium-dependent and -independent relaxations
Rings, with or without endothelium, were contracted with phenylephrine (10 À7 to 10 À6 M) to 80% of the reference contraction to KCl; they were then exposed to cumulative additions of prostacyclin {10 PKA inhibitor) for 45 min before being exposed to increasing concentrations of iloprost. The concentrations of the antagonists/inhibitors used were selected based on earlier work in the laboratory and/or from the literature (Supporting Information Table S1 ).
TP-receptor induced contractions
U46619 (10 À9 to 10 À6 M, TP receptor agonist) was added cumulatively to quiescent rings.
Cyclic nucleotide measurements
Aortae were quickly frozen in liquid nitrogen after treatment and homogenized in HCl (0.1 M). The cAMP and cGMP levels in the aorta were measured using cAMP and cGMP complete ELISA kits, respectively, according to the instructions of the manufacturer (Enzo Life Sciences Inc., Farmingdale, NY, USA).
Apolipoprotein E measurement
Blood was collected in ApoE +/+ and ApoE À/À mice at different ages in the presence of heparin (Leo Pharma A/S, Ballerup, Danmark). The blood was centrifuged at 775× g for 10 min. The upper layer was collected, and the apolipoprotein E level was measured using a mouse apolipoprotein E-ELISA kit, according to the instructions of the manufacturer (Abcam, Cambridge, UK). 
Western blotting
Data and statistical analysis
The data and statistical analysis comply with the recommendations on experimental design and analysis in pharmacology (Curtis et al., 2018) . Relaxations are expressed as percentage changes in tension from the pre-contraction to phenylephrine; contractions are expressed as percentage of the reference response to 60 mM KCl (obtained at the beginning of the experiment). The responses were also analysed by comparing the areas under the concentration-response curve (AUC; Detremmerie et al., 2016) , or the EC50 and Emax (Lee et al., 2011) . Concentration-response curves were plotted using Prism version 5 (GraphPad Software, San Diego, CA, USA). 
Nomenclature of targets and ligands
Key protein targets and ligands in this article are hyperlinked to corresponding entries in http://www. guidetopharmacology.org, the common portal for data from the IUPHAR/BPS Guide to PHARMACOLOGY (Harding et al., 2018) , and are permanently archived in the Concise Guide to PHARMACOLOGY 2017/18 (Alexander et al., 2017a,b,c) .
Results
Vascular responsiveness
Endothelium-dependent relaxations Prostacyclin. Prostacyclin (10 À9 to 10 À6 M) concentrationdependently relaxed phenylephrine-contracted aortae of 5-week-old ApoE +/+ and ApoE À/À mice fed NC. The relaxations were significantly larger in the latter ( Figure 1 ). In both ApoE +/+ and ApoE À/À rings, they were abolished by
Figure 1 Aortae [with (+EC; n = 13/17 for prostacyclin, 25/23 for iloprost) or without (-EC; n = 5/5 for prostacyclin, 5/5 for iloprost) endothelium] of 5-week-old ApoE +/+ (A and C) and ApoE À/À (B and D) mice were incubated (45 min) with vehicle or with L-NAME (10 À4 M; eNOS inhibitor; n = 6/5 for prostacyclin, 7/6 for iloprost), CAY10441 (10 À6 M; IP receptor antagonist; n = 5/6 for prostacyclin, 7/6 for iloprost). The rings were then contracted with phenylephrine (10 À7 to 10 À6 M; α 1 -adrenergic agonist). They were then exposed to cumulatively increasing concentrations Figure S1 ), demonstrating that they are not mediated by activation of EP receptors. Iloprost-induced relaxations in ApoE À/À mouse aortae were also not affected significantly by the combination of DETCA (10 À3 M; Cu/Zn SOD inhibitor) plus Tiron (10 À4 M; superoxide scavenger) (Supporting Information Figure S1 ), indicating that superoxide anions are unlikely to contribute under the present experimental conditions, although an increased superoxide anion production has been associated with apolipoprotein E deletion (Gödecke et al., 2002) . Adult mice: The relaxations to iloprost were compared in aortae of 34-week-old ApoE +/+ and ApoE À/À mice fed NC.
The concentration-dependent relaxations to iloprost were comparable to those observed in aortae of 5-week-old mice of the two strains and were also not affected by the combination of DETCA plus Tiron (Supporting Information Figure S1 ).
Figure 2
Aortae [with (+EC; n = 25/23) or without (-EC; n = 5/5) endothelium] of 5-week-old ApoE +/+ and ApoE À/À mice were incubated (45 min) with vehicle or with L-NAME (10 À4 M; eNOS inhibitor; n = 7/6), CAY10441 (10 À6 M; IP receptor antagonist; n = 7/6), Rp-8-Br-cAMPs (5 × 10 À5 M; PKA inhibitor; n = 5/5), ODQ (10 À5 M; sGC inhibitor; n = 5/5), carboxy-PITIO (3 × 10 À4 M; NO scavenger; n = 5/5), L-cysteine (3 × 10 À3 M; NO scavenger; n = 5/5), calcium-free solution (n = 9/6) or thapsigargin (10 À6 M; SERCA inhibitor; n = 5/5) and contracted with phenylephrine (10 À7 to 10 À6 M). They were then exposed to cumulatively increasing concentrations (10 À9 to 10 À6 M) of iloprost; 'n' refers to the number of ApoE
group/the number of ApoE À/À group respectively. Responses are expressed as AUCs of the concentration-response graphs. Data are shown as means ± SEM, *P ≤ 0.05, significantly different from control (+EC); # P ≤ 0.05, significant difference between ApoE +/+ and ApoE À/À mice.
However, compared to ApoE +/+ preparations, they were significantly greater in ApoE À/À aortae of the same age groups (Figure 3 ). While L-NAME prevented iloprost-induced relaxations in aortae of the ApoE +/+ groups, in aortic rings of the ApoE À/À mice, it only significantly inhibited the response (Figure 3 ). The residual relaxations in the presence of L-NAME in aortae of 34-week-old ApoE À/À mice were not significantly affected by endothelium-removal, by incubation with indomethacin or with the combination of TRAM-34 (10 À6 M) plus UCL1684 (10 À6 M) [inhibitors of intermediate-and small-conductance calcium-activated potassium channels, respectively, which when given in combination prevent endothelium-dependent hyperpolarization (EDH) (Félétou and Vanhoutte, 2006) ] (Supporting Information Figure S1 ). Impairment of the endothelial NO-pathway facilitates other major vasodilator signals, namely release of PGs and EDH, which may compensate for the impairment (Csányi et al., 2012; Vanhoutte et al., 2016) . However, such compensation is unlikely to account for the L-NAME-insensitive relaxation to iloprost in aortae of 34-week-old ApoE À/À mice because they were not prevented by endothelium-removal, by indomethacin or by the inhibitors of the EDH-pathway and thus must be initiated directly at the level of the vascular smooth muscle cells. The most likely explanation for this persistent relaxation is stimulation of IP receptors of the latter leading to activation of AC increasing the production of cAMP, as demonstrated by the increased levels of the cyclic nucleotide in rings without endothelium exposed to iloprost (Figure 4 ). High-fat and high-cholesterol diet: In aortae of 34-week-old ApoE +/+ mice fed HFD, iloprost did not induce relaxations.
The TP receptor antagonist S18886 (10 À7 M), but not indomethacin, unmasked a relaxation (Figure 3 ). After longterm HFD, the plasma cholesterol and triglycerides levels of ApoE À/À mice were augmented significantly compared to those of ApoE +/+ of the same age group (Table 2) , which may account for their significantly lower body weight (d'Uscio et al., 2002) . The aortic areas covered with atherosclerotic lesions significantly increased compared to ApoE À/À mice of the same age fed NC (Supporting Information Figure S3 ). ACh-induced relaxations were comparable in rings with or without atherosclerotic lesions of ApoE À/À HFD aortae (Supporting Information Figure S3 ), while iloprost-induced relaxations were not affected significantly by the combination of DETCA plus Tiron (Supporting Information Figure S1 ) or by S18886 ( Figure 3 ) and did not differ significantly from those observed in aortae of young ApoE À/À animals (Supporting Information Figure S1 ).
Figure 3
Aorta, with endothelium, of 34-week-old (34W) ApoE +/+ (A) and ApoE À/À (B) mice fed with NC were incubated (45 min) with vehicle (n = 11/12), or with L-NAME (10 À5 M; eNOS inhibitor; n = 6/14). Aortae, with endothelium, of 34-week-old (34W) ApoE +/+ (C) and ApoE À/À (D) mice fed with HFD were incubated (45 min) with vehicle (n = 12/5) or with S18886 (10 À7 M; TP receptor antagonist, n = 6/5), indomethacin (3 × 10 À5 M; INDO, non-selective COX inhibitor; n = 5/5), CAY10441 (10 À6 M; IP receptor antagonist; n = 6/5). Rings were contracted with phenylephrine (10 À7 to 10 À6 M). They were then exposed to cumulatively increasing concentrations (10 À9 to 10 À6 M) of iloprost. Responses are expressed as percentage of the phenylephrine-induced contraction; 'n' refers to the number of ApoE +/+ group/the number of ApoE À/À group respectively. Data are shown as means ± SEM. *P ≤ 0.05, significantly different from control.
In aortae of 34-week-old HFD ApoE À/À mice, incubation
(1 h) with exogenous apolipoprotein E (20 μg·mL À1 ) significantly inhibited the relaxations induced by iloprost ( Figure 5A ).
Acetylcholine. ACh-induced relaxations were comparable in preparations of both 5-and 34-week-old ApoE +/+ mice, without or with HFD, but significantly impaired in those of ApoE À/À compared with age-matched ApoE +/+ mice; consistently, ACh-induced relaxations were also impaired significantly in aortae of 34-week-old HFD ApoE À/À mice, compared with the same age ApoE +/+ mice with HFD ( Figure 5B , Table 3 ). These findings demonstrate/confirm that apolipoprotein E deletion per se is associated with impaired NO-dependent relaxations to ACh, irrespective of age and exposure to HFD (Lee et al., 2011; Vanhoutte, 2016) .
Endothelium-independent relaxations. The NO donor detaNONOate induced concentration-dependent relaxations in pre-contracted aortae without endothelium; the relaxations were comparable between preparations of the different ApoE +/+ and ApoE À/À groups ( Figure 5C ).
Endothelium-independent contractions. The reference contractions to KCl were significantly increased in aortae of 34-week-old compared with 5-week-old ApoE +/+ and ApoE À/À mice; HFD significantly impaired contractions to KCl in both ApoE +/+ and ApoE À/À aortae ( Table 3 ).
The TP receptor agonist U46619 induced concentrationdependent contractions in aortae without endothelium; the contractions were comparable between preparations of the different ApoE +/+ groups. In preparations of HFD ApoE À/À mice, the contractions were significantly larger than in those of age-matched HFD ApoE +/+ mice and of the young NC ApoE À/À mice ( Figure 5D ). The EC 50 and maximal contractions for U46619 in aortae with endothelium were not significantly different between preparations of NC or HFD ApoE +/+ mice, but significantly higher in HFD ApoE À/À (Table 3) . The accepted pathway underlying IP receptor-triggered relaxations involves the production of cAMP with the subsequent activation of PKA (Breyer et al., 2001) . The findings in ApoE +/+ preparations that iloprost causes an increase in tissue levels of cAMP, sensitive to CAY10441, combined with the observation that the PKA inhibitor Rp-8-Br-cAMPs (Gjertsen et al., 1995) abolished the relaxation caused by the IP receptor-agonist (Figure 2 ), demonstrate and confirm the involvement of the AC/cAMP signalling cascade in IP receptor-induced relaxations (Shimokawa et al., 1988) .
cGMP. Iloprost induced a significant increase in cGMP level in aortae (with, but not without endothelium) of 5-week-old ApoE +/+ , but not in those of ApoE À/À mice. In these mice, iloprost-induced increases in cGMP level were abolished by CAY10441 and ODQ (Figure 4 ). These observations confirm the involvement of the NO-sGC-cGMP pathway in Figure 4 Levels of cAMP (A) and cGMP (B) in aortic rings, with (+) or without (À, n = 5/5 for cAMP; n = 5/5 for cGMP) endothelium, whether untreated (control; n = 9/6 for cAMP; n = 5/5 for cGMP) or exposed to iloprost (10 À5 M; 30 min; n = 9/6 for cAMP; n = 5/5 for cGMP), in the absence or presence of CAY10441 (10 À6 M, CAY; 45 min of incubation; IP receptor antagonist; n = 6/5 for cAMP; n = 5/5 for cGMP), ODQ (10 À5 M;
45 min of incubation; sGC inhibitor, n = 9/6 for cAMP; n = 9/6 for cGMP), of 5-week-old (5W) ApoE +/+ and ApoE À/À mice fed with NC; 'n' refers to the number of ApoE +/+ group/the number of ApoE À/À group respectively. Results are presented as pmol of the cyclic nucleotide per mg protein of the respective samples. Data are shown as means ± SEM. *P ≤ 0.05, significantly different from control; # P ≤ 0.05, significantly different from iloprost (+) group; $ P ≤ 0.05, significant difference between ApoE +/+ and ApoE À/À mice. 
Table 2
Body weight and plasma lipid levels in ApoE (Figure 6 ).
Western blotting
Nitric oxide synthase. Protein levels of both total and phosphorylated eNOS (at Ser 1177 ) were reduced significantly by endothelium-removal (Figure 7) . Protein levels of total eNOS were comparable in quiescent aortae (with endothelium) of young ApoE +/+ and ApoE À/À mice, and the ratio of phosphorylated to total eNOS was not significantly different between the two groups ( Figure 7) . Total eNOS protein levels as well as the ratio of phosphorylated to total eNOS was significantly reduced in the aortae of adult ApoE À/À compared to those of ApoE +/+ mice of the same age ( Figure 7 ). HFD significantly reduced the phosphorylated eNOS protein levels, as well as the phosphorylated to total eNOS ratio in aortae of adult ApoE À/À mice compared with ApoE +/+ mice ( Figure 7 ).
Iloprost did not significantly affect the aortic protein levels of total and phosphorylated eNOS or the phosphorylated to total eNOS ratio in preparations of young or adult ApoE +/+ and ApoE À/À mice whether fed NC or HFD (Supporting Information Figure S2 ). In particular, the compound did not increase eNOS phosphorylation at Ser Figure 8) . Apolipoprotein E. The plasma level of apolipoprotein E was comparable between young and adult ApoE +/+ mice but increased significantly after HFD (Figure 9 ). The presence of apolipoprotein E protein was also detected by Western blotting in aortae of young ApoE +/+ mice.
It was significantly higher in the older age group and increased further in the 34-week-old group fed HFD and was significantly reduced by endothelium-removal ( Figure 9 ). As could be expected, apolipoprotein E protein was absent in aortae of ApoE À/À mice ( Figure 9 ). The present experiments do not permit us to conclude whether the apolipoprotein E present in the aorta is produced by local synthesis or taken up from the blood, although the latter explanation is favoured by the parallel increases in serum and aortic levels of the protein after prolonged exposure to HFD.
Discussion
As expected, both prostacyclin and iloprost evoked relaxations of aortae of young mice, inhibited by the selective IP receptor antagonist CAY10441, confirming the involvement of IP receptor-activation in the response to prostacyclin and its analogues reported in isolated arteries of other species, including the human (Baxter et al., 1995; Walch et al., 1999; Jones and Chan, 2001; Xavier et al., 2009; Orie and Clapp, 2011) . As mentioned above, the present findings demonstrate and confirm that relaxations to iloprost in murine aortae are due to the generation of NO by eNOS with its subsequent diffusion to underlying vascular smooth muscle cells and activation of sGC. As the relaxations to iloprost were abolished by CAY10441 and reduced by a PKA inhibitor, the release of NO evoked by iloprost is likely to be downstream of the activation of endothelial IP receptors, the presence of which was demonstrated by the present immunostaining experiments. Here, apolipoprotein E deletion, as expected (Kolovou et al., 2008) , augmented the plasma cholesterol level following chronic exposure to HFD and exacerbated the development of aortic atherosclerotic lesions, confirming the atheroprotective role of the protein. It also expectedly reduced relaxations to the established endothelium-dependent vasodilator ACh (Lee et al., 2011; Vanhoutte et al., 2016) . The comparable relaxations to the NO-donor detaNONOate demonstrate that these blunted responses cannot be attributed to an altered responsiveness of the vascular smooth muscle cells to endothelium-derived NO. In endothelial cells, apolipoprotein E binds to caveolin-1 (which when interacting with eNOS inhibits the enzyme) and in so doing interrupts the formation of inhibitory caveolin-1-eNOS complexes increasing eNOS activity (Yue et al., 2012; Vanhoutte et al., 2016) . Its deletion may result in lesser eNOS activation and this possibility warrants further investigation. KCl (60 mM; n = 14/16/16/16/14/14, from the left to the right group, respectively) or with increasing concentrations (10 À9 to 10 À6 M) of U46619 (TP receptor agonist; n = 5 for the first five groups, n = 10 for HFD-ApoE À/À -34W). Aortic rings, with endothelium, of ApoE +/+ and ApoE À/À mice at five and 34 weeks of age [5W (n = 14/8) and 34W (n = 8/5), respectively] fed NC or HFD (n = 10/5), were exposed to cumulatively increasing concentrations (10 À10 to 10 À5 M) of the endothelium-dependent vasodilator ACh; 'n' refers to of the number of ApoE +/+ group/the number of ApoE À/À group respectively. Data are shown as means ± SEM; the EC 50 was determined by nonlinear regression curve fit (Graphpad Prism 5) and shown as log EC 50 . *P < 0.05, NC-34W significantly different from respective NC-5W. # P < 0.05, HFD-34W significantly different from respective NC-34W. † P < 0.05, ApoE À/À significantly different from respective ApoE +/+ group.
The major, unexpected, finding of the present experiments was that, by contrast to the blunting of the responses to ACh, endothelium-dependent relaxations evoked by IP receptor activation were potentiated in aortae of ApoE À/À mice, irrespective of age and diet. Again, in view of the comparable relaxations to detaNONOate, these augmented responses are not explained by an augmented intrinsic responsiveness of the vascular smooth muscle to endothelium-derived NO. This then suggests a protective effect of apolipoprotein E deletion which is selective for IP receptor activation, as it, per se, enhanced prostacyclin-and iloprost-induced IP receptormediated relaxations, despite an increased plasma lipid level even in young mice. This enhancement was not associated with an increased presence of IP receptors which could explain the augmented relaxation. Thus, apolipoprotein E deletion appears to alter the signalling downstream of IP receptor activation. The finding that in aortae of HFD ApoE À/À mice, exogenous apolipoprotein E protein inhibited the relaxations to iloprost strongly supports this interpretation. IP receptors couple primarily to heterotrimeric G-proteins for signalling, leading to stimulation of AC resulting in the formation of cAMP and activation of PKA causing relaxation of the vascular smooth muscle cells (Breyer et al., 2001) . Compared with preparations of ApoE +/+ mice, apolipoprotein E deletion was accompanied by a higher, but also IPdependent, cAMP-generation in aortae with endothelium of ApoE À/À mice of the same age, which then explains the enhanced relaxation after apolipoprotein E deletion. However, the difference in cAMP level between the two strains disappeared after endothelium-removal indicating that the relationship between presence of apolipoprotein E and IP receptor-activation is at the endothelial, rather than in the smooth muscle level (where, to judge from the comparable changes in cAMP production in preparations without endothelium, the direct activation of IP receptors is not modulated by apolipoprotein knockout), which then may be responsible for the protective effect of apolipoprotein E deletion. The findings that IP receptor activation increases the levels of both cAMP and cGMP in the mouse aorta with endothelium and that the increases of the two cyclic nucleotides require the activation of sGC (as they are inhibited by ODQ) confirmed the involvement of the NO-sGC-cGMP pathway in the response (Shimokawa et al., 1988; Zellers et al., 2000; Niwano et al., 2003; Xavier et al., 2009) , but raised the question of how and where this pathway interacts with AC-cAMP signalling during iloprost-induced relaxations.
The absence of significant increases in cGMP levels in preparations without endothelium of ApoE +/+ mice exposed to iloprost and the striking absence of production of this cyclic nucleotide in ApoE À/À aortae imply that the interaction occurs mainly in the endothelium and that it is absent after apolipoprotein E deletion. These observations would be explained if increases in cGMP production in the endothelial cells exert a negative feedback on IP receptor activation, illustrating the role of NO as gatekeeper of endotheliumdependent responsiveness (Félétou et al., 2012) . Inhibition of sGC only caused partial inhibition in ApoE À/À preparations, suggesting the presence of an sGCindependent pathway mediating the NO-dependent relaxations to iloprost. In line with this interpretation, compared with ApoE +/+ aortae, no significant increases in cGMP level were observed in ApoE À/À preparations. One of the mechanisms that underlies NO-dependent but cGMP-independent relaxations is activation of SERCA (Klatt and Lamas, 2000; Adachi et al., 2004; Ying et al., 2007) . As the SERCA inhibitor thapsigargin reduced relaxations to iloprost in ApoE À/À aortae to the level observed in ApoE +/+ preparations, the NO-SERCA interactions may explain, or at least contribute to, the greater relaxations in response to iloprost observed in the former. In addition, as the IP receptor agonist causes larger increases in cAMP production in ApoE À/À than in ApoE +/+ preparations, and as these are prevented by ODQ, in the aortae of the former, sGC may be biased towards the production of cAMP rather than cGMP (Beste et al., 2013; Gao and Vanhoutte, 2014) . This interpretation awaits further demonstration. Increases in age per se did not appear to affect the degree of iloprost-induced relaxations in murine aortae, but they were ; # P ≤ 0.05, significant difference between same age with or without endothelium.
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affected by long-term exposure to HFD which, expectedly (e.g. Winzell and Ahren, 2004) , resulted in increases in body weight and plasma lipid levels in both ApoE +/+ and ApoE
mice. In aortae of the former but not those of the latter, the response to iloprost was shifted from relaxation to contraction. This shift can be attributed to TP receptor activation as the selective TP receptor blocker S18886 (Simonet et al., 1997) restored relaxations to a level comparable to that of preparations of NC mice of the same age, an observation consistent with the unchanged total cell protein presence or membrane pool of IP receptors. To judge from the similarity of the contractions evoked by the selective TP receptor agonist U46619 (Muzaffar et al., 2004) Hence, the possibility must be considered that the reversal from contraction to relaxation effected by S18886 is due to antagonizing endothelial TP receptors, which then would mean that their activation exerts a negative feedback on either IP receptors or eNOS. Both IP and TP receptors can form homo-and heterodimers (Wilson et al., 2004; Laroche et al., 2005; Chakraborty et al., 2013) . The hetero-dimerization of IP and TP receptors can lead to cAMP generation by TP agonists and unmask TPmediated responses with IP agonists (Ibrahim et al., 2010) . Hence, alteration in the ratio of homo-and hetero-dimers of IP and TP receptors could induce changes in iloprost-induced responses. Even if iloprost has minimal effects on homodimers of TP receptors under normal conditions, in the presence of apolipoprotein E, combined with hyperlipidaemic conditions, it may activate IP/TP hetero-dimers causing contraction, thereby counteracting the relaxation due to IP receptor activation. This interpretation warrants further investigation. If it were confirmed, the present observations would imply that apolipoprotein E deletion, by preventing such hetero-dimerization, may protect IP agonists against activation of IP/TP receptor hetero-dimers and thus maintain a response due solely to IP receptor homo-dimers. Indeed, in both young and adult (in particular during HFD) mice, apolipoprotein E deletion per se protected the relaxations to iloprost, despite a reduced protein presence of membrane IP receptors. Furthermore, in HFD ApoE À/À mice, the TP receptor antagonist S18886 did not affect while the exogenous application of apolipoprotein E inhibited iloprost-induced relaxations thus confirming that the absence of apolipoprotein E favours the coupling of iloprost to IP receptor homodimers. To judge from the results obtained with U46619 and the Western blotting measurements in HFD ApoE À/À mice, the increased sensitivity, despite the lower membrane protein presence, may reflect a higher ratio of TP receptor being presented as homodimers under conditions of hyperlipidaemia coupled with apolipoprotein E deletion.
In conclusion, in the aorta of young healthy mice, activation of IP receptors results in endothelium-dependent relaxations which involve both the cGMP and cAMP pathways. While apolipoprotein E deficiency is detrimental as regards the regulation of plasma cholesterol levels and hence promotes atherogenesis, it potentiates the relaxations to IP receptor activation in the aorta of the ApoE À/À mouse, irrespective of age and diet. The present findings thus indicate that iloprost may exert a favourable effect on apolipoprotein allele-related cardiovascular disorders.
Figure 9
Protein levels of apolipoprotein E in aortae, with (+) and without (À) endothelium, of 5-and 34-week-old (5W and 34W, respectively) ApoE +/+ and ApoE À/À mice fed NC or HFD (A and B; n = 5 for all groups). Plasma levels of apolipoprotein E in 5-and 34-week-old (5W; n = 5/5 and 34W; n = 6/4, respectively) ApoE +/+ and ApoE À/À mice fed NC or HFD (C; n = 5/5). Protein levels are shown as representative blots (A) or as ratio of the OD of the protein bands to the corresponding β-actin bands (B). Plasma apolipoprotein E levels are shown as ng·mL À1 (C). Data are shown as means ± SEM;
'n' refers to the number of ApoE +/+ group/the number of ApoE À/À group, respectively. * P ≤ 0.05, significant difference between the same group ApoE +/+ and ApoE À/À ; # P ≤ 0.05, significant difference between same age with or without endothelium; $ P ≤ 0.05, significant difference in apolipoprotein E presence between NC-34W and the respective HFD-34W. 
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https://doi.org/10.1111/bph.14386 (   Table S1 List of chemicals with information on their pharmacological action, and the concentration and preparation (solvent) used in the present study. UCL, small-conductance calcium-activated potassium channel inhibitor; n = 6)]. Aortic rings, with endothelium, of ApoE À/À mice at five (G) and 34 weeks of age (H) fed normal chow (NC) or high-fat & high-cholesterol diet (HFD, I) were contracted with phenylephrine (10 À7 to 10 À6 M). They then were exposed to cumulatively increasing concentrations (10 À9 to 10 À6 M) of iloprost.
Responses are expressed as percentage of the phenylephrineinduced contraction. Data shown as means ± SEM, "*" indicates statistically significant difference (P ≤ 0.05) from respective control. . Aortae, after removing the surrounding connective tissue and fat, were cut longitudinally and fixed in 60% isopropanol for 15 minutes, followed by incubation in 0.3% freshly prepared Oil Red O solution (Sigma) for another 15 minutes. After rinsing with 60% isopropanol for three minutes, the preparations were washed three times with phosphate-buffered saline and images were taken en face with a digital camera (Olympus U-TVX1X-2, Olympus, Tokyo, Japan); the lesion areas were analyzed with Image J software (National Institutes of Health, Bethesda, MD, USA). Rings of 34 weeks old (34W) ApoE À/À mice (n = 6) fed high-fat & high-cholesterol diet (HFD), with or without atherosclerotic lesions (B, Right), were contracted with phenylephrine (10 À7 to 10 À6 M). They then were exposed to cumulatively increasing concentrations (10 À10 to 10 À5 M) of acetylcholine.
Responses are expressed as percentage of the phenylephrine-induced contraction (B, Left). Data shown as means ± SEM. Oil Red O staining.
